Thérèse Keravis - Concepedia

Author

Thérèse Keravis

Centre National de la Recherche Scientifique

Also Known As

Keravis, T., T KERAVIS, T Keravis, T M Keravis, T. Keravis, T.M Keravis, Therese Keravis, Therese M. Keravis, Thérèse Keravis, Thérèse Keravis

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Centre National de la Recherche Scientifique Université de Strasbourg Laboratoire de Biophotonique et Pharmacologie Laboratoire de Chimie Moléculaire Université de Sherbrooke

About

Thérèse Keravis is an author at Centre National de la Recherche Scientifique specializing in medicine, pharmacology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	557
2	Biochemistry	6	6	333
3	Natural Sciences	4	4	160
4	Health Sciences	1	1	30
5	Allergy	1	1	26

Thérèse Keravis

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Anti‐proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1 Abdurazzag Abusnina, Thérèse Keravis, Issaka Yougbaré, Molecular Nutrition & Food Research	2011	111
VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors Laure Favot, Thérèse Keravis, Vincent Holl, Thrombosis and Haemostasis Pde4 InhibitorsAngiogenesisSignal TransductionMedicineEndothelial Dysfunction	2003	101
Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis Laure Favot, Sophie Martin, Thérèse Keravis, Cardiovascular Research	2003	92
Red Wine Polyphenolic Compounds Inhibit Vascular Endothelial Growth Factor Expression in Vascular Smooth Muscle Cells by Preventing the Activation of the p38 Mitogen-Activated Protein Kinase Pathway Min-Ho Oak, Marta Chataigneau, Thérèse Keravis, Arteriosclerosis Thrombosis and Vascular Biology	2003	85
Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis Abdurazzag Abusnina, Mahmoud Alhosin, Thérèse Keravis, Cellular Signalling Uhrf1 DeregulationMalignant Blood DisorderApoptosisImmunologyKey Event	2010	82
Section Review: Cardiovascular & Renal: Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiovascular diseases Jean‐Claude Stoclet, Thérèse Keravis, Narcisse Komas, Expert Opinion on Investigational Drugs PharmacotherapyPde InhibitorsCyclic Nucleotide PhosphodiesterasesCardiovascular DiseasesSection Review	1995	65
Characterization of cyclic nucleotide phosphodiesterase isoforms associated to isolated cardiac nuclei Claire Lugnier, Thérèse Keravis, Alain Le Bec, Biochimica et Biophysica Acta (BBA) - General Subjects Cardiac MuscleCardiomyopathyCardiac NucleiBiochemistryNatural Sciences	1999	64
Cyclic nucleotide phosphodiesterase activities from pig coronary arteries. Lack of interconvertibility of major forms Thérèse Keravis, Jack N. Wells, J. G. Hardman Biochimica et Biophysica Acta (BBA) - Enzymology Molecular PharmacologyVascular DiseaseMolecular PhysiologyBiochemistryCardiovascular Disease	1980	64
Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II Walid Mokni, Thérèse Keravis, Nelly Étienne-Selloum, PLoS ONE Cardiac MuscleHypertensionHeart FailureCardiovascular PharmacologyCardiovascular Function	2010	60
Modulation of VEGF-induced endothelial cell cycle protein expression through cyclic AMP hydrolysis by PDE2 and PDE4 Laure Favot, Thérèse Keravis, Claire Lugnier Thrombosis and Haemostasis	2004	60

Page 1